PDF(Pubmed)
Abstract：
Avoidant/restrictive food intake disorder (ARFID) is an eating disorder recently codified in DSM-5 that affects individuals of all ages. A proliferation of ARFID research has emerged over the years, and this review provides a brief overview of the current understanding of ARFID epidemiology, symptoms, comorbid conditions, assessment, and treatment. The review highlights recent research updates regarding ARFID among adults, putative neurobiological mechanisms underlying ARFID, and new treatment trials. Findings from this review demonstrate that ARFID is as prevalent as other eating disorders, even among adults, and is associated with significant medical and psychiatric comorbid conditions. New, promising treatments for children, adolescents, and adults are in the early stages of development. Several assessments are now available to aid in the screening and diagnosis of ARFID and have demonstrated cross-cultural validity. Areas for future research and clinical guidance, including unresolved questions regarding ARFID categorization and differential diagnosis, are discussed.
摘要：
避免性/限制性食物摄入障碍（ARFID）是最近在DSM-5中编码的饮食障碍，影响所有年龄段的个体。多年来，ARFID研究激增，这篇综述简要概述了当前对ARFID流行病学的理解，症状,合并症条件，评估，和治疗。该评论重点介绍了有关成人ARFID的最新研究，ARFID潜在的假定神经生物学机制，和新的治疗试验。这篇综述的结果表明，ARFID与其他饮食失调一样普遍，即使是成年人，并与严重的医疗和精神合并症有关。新,对儿童有希望的治疗方法，青少年,成年人处于发育的早期阶段。现在有几项评估可以帮助筛查和诊断ARFID，并证明了跨文化的有效性。未来研究和临床指导领域，包括关于ARFID分类和鉴别诊断的未解决的问题，正在讨论。
